Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1461155012 | Daclizumab (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 1481091011 | Daclizumab | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 25851000188118 | Daclizumab | fr | Synonym (core metadata concept) | Inactive | Entire term case sensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
| 803581000172119 | daclizumab | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Daclizumab (substance) | Is a | agent d'anticorps monoclonal | false | Inferred relationship | Some | ||
| Daclizumab (substance) | Is a | anticorps monoclonal chimérique souris-humain d'isotype IgG | false | Inferred relationship | Some | ||
| Daclizumab (substance) | Has disposition (attribute) | Murine-human monoclonal immunoglobulin G antibody | false | Inferred relationship | Some | ||
| Daclizumab (substance) | Has disposition (attribute) | Immunomodulator (disposition) | true | Inferred relationship | Some | ||
| Daclizumab (substance) | Is a | Immunosuppressant (substance) | true | Inferred relationship | Some | ||
| Daclizumab (substance) | Is a | Monoclonal antibody | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing daclizumab (medicinal product) | Has active ingredient | True | Daclizumab (substance) | Inferred relationship | Some | 1 |
| Daclizumab 25mg/5 mL solution | Has active ingredient | False | Daclizumab (substance) | Inferred relationship | Some | |
| Daclizumab 25mg/5mL infusion concentrate | Has active ingredient | False | Daclizumab (substance) | Inferred relationship | Some | |
| Daclizumab 25mg/5mL conventional release solution for injection | Has active ingredient | False | Daclizumab (substance) | Inferred relationship | Some | |
| Product containing only daclizumab (medicinal product) | Has active ingredient | True | Daclizumab (substance) | Inferred relationship | Some | 1 |
| Daclizumab only product in parenteral dose form | Has active ingredient | True | Daclizumab (substance) | Inferred relationship | Some | 1 |
| Product containing daclizumab in parenteral dose form (medicinal product form) | Has active ingredient | True | Daclizumab (substance) | Inferred relationship | Some | 1 |
This concept is not in any reference sets
FHIR